Valneva SE Actions au Porteur E (AYJ.MU)

Munich - Munich Delayed Price. Currency in EUR

Add to watchlist

10.27

-0.39

(-3.66%)

At close: 02:13PM CEST

Advertisement

Full screen

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	10.65
Open	11.45
Bid	10.10 x 0
Ask	10.30 x 0
Day's Range	10.27 - 10.65
52 Week Range	7.28 - 30.68
Volume	220
Avg. Volume	644

Market Cap	N/A
Beta (5Y Monthly)	N/A
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for AYJ.MU

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

All

News

Press Releases

Motley Fool
How Pfizer Plans to Unlock Another Mass-Market Vaccine
As the first company to introduce a COVID-19 vaccine, pharmaceutical behemoth Pfizer (NYSE: PFE) experienced enormous windfalls by delivering primary and booster shots on a global scale. Now, Pfizer is developing a vaccine for another infectious disease with a wide-open market. Pfizer will invest about $95 million in specialty vaccine maker Valneva, based in France.
GlobeNewswire
Valneva SE Declaration of shares and voting rights - Interim status at June 22, 2022
VALNEVA Declaration of shares and voting rights Interim status at June 22, 2022__________________________________________________________________________________________ Company name: VALNEVARegistered office: 6 rue Alain Bombard, 44800 Saint-Herblain (France)Regulated market of Euronext Paris - Compartment A Declaration date: June 27, 2022 Number of shares composing the share capital of Valneva Total number of voting rights including suspended voting rights* Description of the change Date on wh
- SpineGuard Reports on Its Annual Shareholders’ Meeting of June 30, 2022
  Business Wire
- Outlook (guidance) 2022
  GlobeNewswire
GlobeNewswire
Valneva Announces Successful Outcome of its AGM and Appointment of two New Supervisory Board Members
Saint-Herblain (France), June 24, 2022 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced that all the resolutions recommended by the Management Board were approved by the shareholders at its Annual General Meeting (AGM) held yesterday in Paris. Among the adopted resolutions were approval of the 2021 financial statements, delegations for the management board to increase Valneva’s share capital and/or issue financial instruments, and the appointment, fo